SHANNON CURRIER
Prescription History 1982980090
Optometrist in Bozeman, MT
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for SHANNON CURRIER, an active Optometrist specialist practicing in Bozeman, MT. Our medical registry currently tracks 11 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 343 documented patient claims. Among these therapy options, the most frequently utilized medication is Latanoprost, which accounts for 139 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2024)Rx (2024) | Avg Cost per FillCost / Fill | Vs. Other MT PrescribersVs. MT Avg |
|---|---|---|---|
| Latanoprost | 139 | $15.67 | ≈ Typical |
About Latanoprost: Latanoprost is used to treat high pressure inside the eye due to glaucoma (open angle type) or other eye diseases (such as ocular hypertension). Show more ▾ It is similar to a natural chemical in the body (prostaglandin) and works by regulating the flow of fluid within the eye which results in lower pressure. Lowering high pressure inside the eye helps to prevent blindness. A prostaglandin F analog used to treat OCULAR HYPERTENSION in patients with GLAUCOMA. In 2024, this provider wrote 139 Medicare prescriptions for Latanoprost, about the same volume as the typical Montana prescriber of this medication (122.1). Medicare paid an average of $15.67 per fill, versus $11.98 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MT prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 283.4 30-Day Fills standardized to 30-day supplies 8,253 Days of Medication total across all patients in 2024 | |||
| LumiganBimatoprost | 37 | $402.00▼ below MT avg | ≈ Typical |
About Lumigan: Bimatoprost is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye can help prevent blindness. This medication works by regulating the flow of fluid within the eye to maintain a normal pressure. A cloprostenol-derived amide that is used as an ANTIHYPERTENSIVE AGENT in the treatment of OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION. In 2024, this provider wrote 37 Medicare prescriptions for Lumigan, about the same volume as the typical Montana prescriber of this medication (37.3). Medicare paid an average of $402.00 per fill, versus $458.17 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MT prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MT average for this medication. 58.5 30-Day Fills standardized to 30-day supplies 1,668 Days of Medication total across all patients in 2024 | |||
| Timolol Maleate | 33 | $16.72 | ▼ Less than typical |
About Timolol Maleate: This medication is used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. Timolol belongs to a class of drugs known as beta-blockers. A beta-adrenergic antagonist that is similar in action to PROPRANOLOL; the levo-isomer is more active. Timolol has been proposed as an anti-hypertensive, anti-arrhythmic, anti-angina, and anti-glaucoma agent. It is also used in the treatment of MIGRAINE DISORDERS and tremor. In 2024, this provider wrote 33 Medicare prescriptions for Timolol Maleate, about half the volume of the typical Montana prescriber of this medication (60.9). Medicare paid an average of $16.72 per fill, versus $13.34 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MT prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 63.7 30-Day Fills standardized to 30-day supplies 1,912 Days of Medication total across all patients in 2024 | |||
| Brimonidine Tartrate | 26 | $40.09 | ▼ Less than typical |
About Brimonidine Tartrate: This medication is used to treat open-angle glaucoma or high fluid pressure in the eye. Show more ▾ Lowering high fluid pressure in the eye reduces the risk of vision loss, nerve damage, or blindness. This medication lowers pressure by allowing better fluid drainage from within the eye and also by reducing the amount of fluid formed in the eye. It is known as an alpha agonist. This drug is not recommended for use in children less than 2 years of age due to an increased risk of serious side effects such as very slowed breathing. Ask the doctor or pharmacist for details. A quinoxaline derivative and ADRENERGIC ALHPA-2 RECEPTOR AGONIST that is used to manage INTRAOCULAR PRESSURE associated with OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION. In 2024, this provider wrote 26 Medicare prescriptions for Brimonidine Tartrate, about half the volume of the typical Montana prescriber of this medication (53.6). Medicare paid an average of $40.09 per fill, versus $33.55 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MT prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 48.5 30-Day Fills standardized to 30-day supplies 1,421 Days of Medication total across all patients in 2024 | |||
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 23 | $11.67▼ below MT avg | ▼ Less than typical |
About Neomycin-Polymyxin-Dexameth: This medication is used to treat conditions involving swelling (inflammation) of the eyes and to treat or prevent bacterial eye infections. Show more ▾ This product contains neomycin and polymyxin, antibiotics that work by stopping the growth of bacteria. It also contains dexamethasone, an anti-inflammatory corticosteroid that works by reducing swelling. This medication treats/prevents only bacterial eye infections. It will not work for other types of eye infections and may worsen them (such as infections caused by viruses, fungi, mycobacteria). Unnecessary use or overuse of any antibiotic can lead to its decreased effectiveness. In 2024, this provider wrote 23 Medicare prescriptions for Neomycin-Polymyxin-Dexameth, about 66% of the volume of the typical Montana prescriber of this medication (35). Medicare paid an average of $11.67 per fill, versus $12.10 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MT prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MT average for this medication. 23 30-Day Fills standardized to 30-day supplies 312 Days of Medication total across all patients in 2024 | |||
| RocklatanNetarsudil Mesylat/Latanoprost | 18 | $579.98 | ▼ Less than typical |
About Rocklatan: Netarsudil/latanoprost is used to treat high pressure inside the eye due to certain eye conditions (such as open-angle glaucoma, ocular hypertension). Show more ▾ Lowering high pressure inside the eye can help prevent vision loss or blindness. In 2024, this provider wrote 18 Medicare prescriptions for Rocklatan, about half the volume of the typical Montana prescriber of this medication (40). Medicare paid an average of $579.98 per fill, versus $498.51 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MT prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 26.3 30-Day Fills standardized to 30-day supplies 725 Days of Medication total across all patients in 2024 | |||
| ErythromycinErythromycin Base | 15 | $10.91▼ below MT avg | ▼ Less than typical |
About Erythromycin: This medication is used to treat certain eye infections (such as conjunctivitis). Show more ▾ It is also used to prevent certain eye infections in newborns. It belongs to a class of drugs known as macrolide antibiotics. Erythromycin works by stopping the growth of bacteria. This medication treats only bacterial eye infections. It will not work for other types of eye infections. Unnecessary use or misuse of any antibiotic can lead to its decreased effectiveness. A bacteriostatic antibiotic macrolide produced by Streptomyces erythreus. Erythromycin A is considered its major active component. In sensitive organisms, it inhibits protein synthesis by binding to 50S ribosomal subunits. This binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins. In 2024, this provider wrote 15 Medicare prescriptions for Erythromycin, about a third of the volume of the typical Montana prescriber of this medication (36.4). Medicare paid an average of $10.91 per fill, versus $16.03 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MT prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MT average for this medication. 18 30-Day Fills standardized to 30-day supplies 428 Days of Medication total across all patients in 2024 | |||
| Prednisolone Acetate | 15 | $49.78 | ▼ Less than typical |
About Prednisolone Acetate: This medication is used to treat certain eye conditions due to inflammation or injury. Show more ▾ Prednisolone works by relieving symptoms such as swelling, redness, and itching. It belongs to a class of drugs known as corticosteroids. A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states. In 2024, this provider wrote 15 Medicare prescriptions for Prednisolone Acetate, about 18% of the volume of the typical Montana prescriber of this medication (85.4). Medicare paid an average of $49.78 per fill, versus $42.83 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MT prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 16 30-Day Fills standardized to 30-day supplies 334 Days of Medication total across all patients in 2024 | |||
| CequaCyclosporine | 13 | $570.58 | – No State Data |
About Cequa: Cyclosporine eye drops are used to treat a certain type of dry eyes. Show more ▾ They work by increasing the amount of tears you make. A cyclic undecapeptide from an extract of soil fungi. It is a powerful immunosupressant with a specific action on T-lymphocytes. It is used for the prophylaxis of graft rejection in organ and tissue transplantation. (From Martindale, The Extra Pharmacopoeia, 30th ed). In 2024, this provider wrote 13 Medicare prescriptions for Cequa. Medicare paid an average of $570.58 per fill. No state comparison is available for this medication. How often this provider prescribes it No state benchmark is available for this medication. What Medicare paid per fill $570.58 Cost per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 13 30-Day Fills standardized to 30-day supplies 390 Days of Medication total across all patients in 2024 | |||
| ValacyclovirValacyclovir Hcl | 13 | $30.16 | ▼ Less than typical |
About Valacyclovir: Valacyclovir is used to treat infections caused by certain types of viruses. Show more ▾ In children, it is used to treat cold sores around the mouth (caused by herpes simplex) and chickenpox (caused by varicella zoster). In adults, it is used to treat shingles (caused by herpes zoster) and cold sores around the mouth. Valacyclovir is also used to treat outbreaks of genital herpes. In people with frequent outbreaks, this medication is used to reduce the number of future episodes. Valacyclovir is an antiviral drug. It stops the growth of certain viruses. However, it is not a cure for these infections. The viruses that cause these infections continue to live in the body even between outbreaks. Valacyclovir decreases the severity and length of these outbreaks. It helps the sores heal faster, keeps new sores from forming, and decreases pain/itching. This medication may also help reduce how long pain remains after the sores heal. A prodrug of acyclovir that is used in the treatment of HERPES ZOSTER and HERPES SIMPLEX VIRUS INFECTION of the skin and mucous membranes, including GENITAL HERPES. In 2024, this provider wrote 13 Medicare prescriptions for Valacyclovir, about half the volume of the typical Montana prescriber of this medication (22.5). Medicare paid an average of $30.16 per fill, versus $28.06 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MT prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 23 30-Day Fills standardized to 30-day supplies 674 Days of Medication total across all patients in 2024 | |||
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 11 | $19.86 | ▼ Less than typical |
About Dorzolamide-Timolol: This product contains two drugs used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. Timolol belongs to a class of drugs known as beta-blockers, and dorzolamide belongs to a class of drugs known as carbonic anhydrase inhibitors. In 2024, this provider wrote 11 Medicare prescriptions for Dorzolamide-Timolol, about 14% of the volume of the typical Montana prescriber of this medication (78). Medicare paid an average of $19.86 per fill, versus $19.42 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MT prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 22 30-Day Fills standardized to 30-day supplies 660 Days of Medication total across all patients in 2024 | |||
About this data. The prescription history for SHANNON CURRIER is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Optometrist prescribing approach at this Bozeman, MT practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among MT prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.
About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.
